DNLI
Denali Therapeutics Inc
20.50$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 92.4% | 92.2% | 61.6% | 61.8% | 59.8% | 62.9% | 69.1% | 80.1% | 83.6% | 78.7% | 80.8% | 65.1% | |
| 12.0% | 11.0% | 3.8% | 5.0% | 6.2% | 12.7% | 4.5% | 12.1% | 8.6% | 17.9% | 30.6% | 17.4% | |
| 89.7% | 89.7% | 59.3% | 59.6% | 57.5% | 60.6% | 64.3% | 77.1% | 80.4% | 75.8% | 78.0% | 61.4% | |
| – | 0.3% | 0.1% | 0.1% | – | 0.2% | – | 0.1% | 0.2% | 0.2% | 0.1% | 0.3% | |
| – | 0.0% | – | – | – | – | – | – | – | – | – | 0.4% | |
| – | – | – | – | – | – | – | – | – | – | 2.8% | 3.0% | |
| 9.6% | 10.7% | 7.9% | 7.7% | 9.3% | 10.5% | 11.7% | 11.9% | 12.3% | 11.5% | 26.8% | 27.9% | |
| 5.8% | 6.8% | 5.2% | 5.0% | 6.0% | 7.4% | 7.2% | 7.8% | 8.5% | 8.6% | 8.7% | 7.8% | |
| 0.6% | 0.6% | 0.5% | 0.5% | 0.6% | 0.9% | 0.7% | 0.8% | 0.9% | 0.8% | 0.8% | – | |
| 0.1% | 0.8% | 0.7% | 0.9% | 0.7% | 0.8% | 0.7% | 0.9% | 0.6% | 0.3% | 3.2% | 1.0% | |
| 90.4% | 89.3% | 92.1% | 92.3% | 90.7% | 89.5% | 88.3% | 88.1% | 87.7% | 88.5% | 73.2% | 72.1% | |
| -80.6% | -96.7% | -77.0% | -87.7% | -98.0% | -112.0% | -131.5% | -154.0% | -182.2% | -179.2% | -172.2% | -199.3% | |
| 11.1% | 12.0% | 9.4% | 11.2% | 11.7% | 12.4% | 13.5% | 14.7% | 16.3% | 15.3% | 14.7% | 16.2% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.